Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

被引：223
|
作者：
Aldoss, Ibrahim [1 ]
Yang, Dongyun [2 ]
Aribi, Ahmed [1 ]
Ali, Haris [1 ]
Sandhu, Karamjeet [1 ]
Al Malki, Monzr M. [1 ]
Mei, Matthew [1 ]
Salhotra, Amandeep [1 ]
Khaled, Samer [1 ]
Nakamura, Ryotaro [1 ]
Snyder, David [1 ]
O'Donnell, Margaret [1 ]
Stein, Anthony S. [1 ]
Forman, Stephen J. [1 ]
Marcucci, Guido [1 ]
Pullarkat, Vinod [1 ]
机构：
[1] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplant, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Informat Sci, Div Biostat, Duarte, CA USA
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 09期
关键词：
CONVENTIONAL CARE REGIMENS; OLDER PATIENTS; AZACITIDINE; AML; RECOMMENDATIONS; DIAGNOSIS; TARGETS;
D O I：
10.3324/haematol.2018.188094
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E404 / E407
页数：4
相关论文
共 50 条
  • [41] Selinexor in Combination with Hypomethylating Agent (HMA) in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML) Previously Exposed to Venetoclax: A Retrospective Study
    Zhang, Jian
    Song, Baoquan
    Liu, Yin
    Wu, De-Pei
    Qiu, Huiying
    BLOOD, 2023, 142
  • [42] Venetoclax plus hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia Two case reports
    Wang, Hongxia
    Bai, Junjun
    Pei, Zhixin
    Zhang, Bei
    Wang, Junjie
    Lian, Xingli
    Song, Qinglin
    MEDICINE, 2020, 99 (47) : E23265
  • [43] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [44] Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens
    Maiti, Abhishek
    Rausch, Caitlin R.
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Daver, Naval G.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Naqvi, Kiran
    Ohanian, Maro
    Short, Nicholas J.
    Alvarado, Yesid
    Kadia, Tapan M.
    Takahashi, Koichi
    Yilmaz, Musa
    Jain, Nitin
    Kornblau, Steven
    Montalban-Bravo, Guillermo
    Sasaki, Koji
    Andreeff, Michael
    Bose, Prithviraj
    Ferrajoli, Alessandra
    Issa, Ghayas C.
    Jabbour, Elias J.
    Masarova, Lucia
    Thompson, Philip A.
    Wang, Sa
    Konoplev, Sergej
    Pierce, Sherry A.
    Ning, Jing
    Qiao, Wei
    Welch, John S.
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    HAEMATOLOGICA, 2021, 106 (03) : 894 - 898
  • [45] Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective study
    Ram, Ron
    Amit, Odelia
    Zuckerman, Tsila
    Gurion, Ronit
    Raanani, Pia
    Bar-On, Yael
    Avivi, Irit
    Wolach, Ofir
    ANNALS OF HEMATOLOGY, 2019, 98 (08) : 1927 - 1932
  • [46] Efficacy and safety of venetoclax combination therapy for relapsed/refractory acute myeloid leukemia: a systematic review and meta-analysis
    Jiao, Ning
    Shi, Lina
    Wang, Shaohua
    Sun, Yonghao
    Bai, Yujun
    Zhang, Dengshan
    BMC CANCER, 2024, 24 (01)
  • [47] Venetoclax plus Cladribine plus Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax plus Hypomethylating Agent
    Steinauer, Nickolas
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Mangaonkar, Abhishek A.
    Saliba, Antoine
    Hefazi, Mehrdad
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Pardanani, Animesh D.
    Badar, Talha
    Murthy, Hemant S.
    Foran, James M.
    Yi, Cecilia Y. Arana
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2023, 142
  • [48] Venetoclax in Combination with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia Is Comparable to Alternative Regimens
    Miller, Jenn
    Shannon, Lindsey
    Finch, Amanda
    Altman, Jessica K.
    Wojenski, Daniel
    BLOOD, 2020, 136
  • [49] Pegcrisantaspase in Combination with Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: A Phase 1 Study
    Niyongere, Sandrine
    Duong, Vu H.
    Bollino, Dominique R.
    Lapidus, Rena G.
    Strovel, Erin T.
    Zarrabi, Jinoos
    Bah, Osman Mohamed
    Philip, Sunita
    Kflu, Veronica
    Baer, Maria R.
    Emadi, Ashkan
    BLOOD, 2021, 138
  • [50] Novel Combination Therapy of Venetoclax and Ruxolitinib in the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Borate, Uma
    Saultz, Jennifer N.
    Kaempf, Andy
    Minnier, Jessica
    Tognon, Cristina E.
    Kurtz, Stephen E.
    Eide, Christopher A.
    Patel, Prapti A.
    Madanat, Yazan F.
    Clement, Peter
    Avaylon, Sammantha
    Misra, Shikha
    Druker, Brian J.
    Tyner, Jeffrey W.
    BLOOD, 2021, 138
12345